Welcome to hubXchange’s Immuno-Oncology Xchange Boston 2024, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in developing immuno-oncology therapies, through a series of roundtable discussions. Discussion topics will cover Immune Biomarkers, Translational Research, Clinical Development, and Tumor Microenvironment. Take advantage of this unique highly interactive meeting format designed for maximum engagement and collaboration with your peers.